Hybrid Coronary Revascularization Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

Also called NCT03089398

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 200 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03089398
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03089398. Randomized; single masking; primary purpose treatment. Start 2017-10-09 (actual); primary completion 2021-03-31 (actual). Results posted on 2025-05-23.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Hybrid Coronary Revascularization Trial
Intervention (Procedure)
Hybrid Coronary Revascularization (isolated LIMA-LAD)
Intervention (Device)
Hybrid Coronary Revascularization (PCI (percutaneous coronary intervention))
Lead sponsor
Emilia Bagiella (class: other)
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct03089398
Content hash
52ac57a804630b42927127d0f60b6d5d6bcc5e03512e4c06c136b222a699f26f